Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women

Scandinavian Journal of Infectious Diseases

Volumn 34, Issue 3, 2002, Pages 201-204

  Logar, Jernej ^a   Petrovec, Miroslav ^a   Novak Antolič, Živa ^a   Premru Sršen, Tanja ^a   Čižman, Maja ^a   Arnež, Maja ^a   Kraut, Aleksandra ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; FOLINIC ACID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN;

AMNIOCENTESIS; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL TOXOPLASMOSIS; COST BENEFIT ANALYSIS; DIAGNOSTIC ACCURACY; ELECTROENCEPHALOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRENATAL SCREENING; PRIMARY INFECTION; RISK ASSESSMENT; SCREENING TEST; SECOND TRIMESTER PREGNANCY; SEROLOGY; SLOVENIA; SYMPTOM; THIRD TRIMESTER PREGNANCY; TOXOPLASMA GONDII;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIPROTOZOAL AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; SEROLOGIC TESTS; SLOVENIA; TOXOPLASMA; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 0036214869     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540110080386     Document Type: Article

References (27)

1. Sources of toxoplasma infection in pregnant women: European multicentre case-control study
2. Sources of Toxoplasma gondii infection in pregnancy
3. Toxoplasma gondii: From animals to humans
4. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria
5. Problems of congenital toxoplasmosis. Evolution over four decades
6. Control of congenital infection with Toxoplasma gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples
7. Neonatal screening for congenital toxoplasmosis in the Poznan region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots
8. Serological screening for toxoplasmosis in pregnancy in Slovenia
9. Specific IgG avidity - A supplementary assay in serological screening for toxoplasmosis in pregnancy
10. Treatment of toxoplasmosis in pregnant mother and newborn child
11. Congenital toxoplasmosis - Is screening desirable
12. Cost-benefit analysis of screening for toxoplasmosis during pregnancy
13. Prenatal screening for toxoplasmosis
14. Epidemiological study of latent and recent infection by Toxoplasma gondii in pregnant women from a regional population in the UK
15. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway
16. Screening methods for congenital toxoplasma and risk of disease
17. Prevention of congenital toxoplasmosis
18. An investigation into the incidence of toxoplasmosis in pregnancy in New Zealand
19. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden
20. Prophylaxis of congenital toxoplasmosis. Effects of spiramycin on placental infection
21. Congenital toxoplasmosis. A prospective study of the offspring of 542 women who acquired toxoplasmosis during pregnancy
22. 20 annees de depistage de la toxoplasmose chez la femme enceinte l'experience liegeoise sur 20,000 grosseses
23. Congenital toxoplasmosis: 10 year follow-up
24. Treatment of toxoplasmosis during pregnancy: Impact of foetal transmission and children's sequelae at one year of age: A multicenter study
25. Mother-to-child transmission of toxoplasmosis: Risk estimates for clinical counselling
26. Treatment of toxoplasmosis in pregnancy and the infected newborns